Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.550
-0.010 (-0.39%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of $27.37 million as of April 28, 2026. Its market cap has increased by 334.44% in one year.
Market Cap
27.37M
Enterprise Value
18.91M
1-Year Change
334.44%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since March 31, 2015, Aytu BioPharma's market cap has increased from $200.00K to $27.37M, an increase of 13,584.84%. That is a compound annual growth rate of 55.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 27.50M | 3.77% |
| Dec 31, 2025 | 26.50M | 152.38% |
| Dec 31, 2024 | 10.50M | -33.54% |
| Dec 29, 2023 | 15.80M | 33.90% |
| Dec 30, 2022 | 11.80M | -68.95% |
| Dec 31, 2021 | 38.00M | -50.33% |
| Dec 31, 2020 | 76.50M | 278.71% |
| Dec 31, 2019 | 20.20M | 197.06% |
| Dec 31, 2018 | 6.80M | -30.61% |
| Dec 29, 2017 | 9.80M | 9,700.00% |
| Dec 30, 2016 | 100.00K | -66.67% |
| Dec 31, 2015 | 300.00K | 50.00% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Incannex Healthcare | 57.01M |
| InterCure | 49.08M |
| Zhengye Biotechnology Holding | 43.72M |
| Talphera | 38.27M |
| Rockwell Medical | 35.07M |
| BioXcel Therapeutics | 28.70M |
| TherapeuticsMD | 24.31M |
| Apimeds Pharmaceuticals US | 23.64M |